Numerous studies have shown that the overexpression of ITGA5 is linked to unfavorable outcomes in various types of tumors, including triple-negative breast cancer (Xiao et al., 2018), ovarian cancer (Gong et al., 2016), colorectal cancer (Yu et al., 2019) and lung cancer (Zheng et al., 2016). Here, ITGA5 is linked to ovarian cancer.